372 related articles for article (PubMed ID: 24642466)
1. Podocyte-specific RAP1GAP expression contributes to focal segmental glomerulosclerosis-associated glomerular injury.
Potla U; Ni J; Vadaparampil J; Yang G; Leventhal JS; Campbell KN; Chuang PY; Morozov A; He JC; D'Agati VD; Klotman PE; Kaufman L
J Clin Invest; 2014 Apr; 124(4):1757-69. PubMed ID: 24642466
[TBL] [Abstract][Full Text] [Related]
2. MAGI-1 Interacts with Nephrin to Maintain Slit Diaphragm Structure through Enhanced Rap1 Activation in Podocytes.
Ni J; Bao S; Johnson RI; Zhu B; Li J; Vadaparampil J; Smith CM; Campbell KN; Grahammer F; Huber TB; He JC; D'Agati VD; Chan A; Kaufman L
J Biol Chem; 2016 Nov; 291(47):24406-24417. PubMed ID: 27707879
[TBL] [Abstract][Full Text] [Related]
3. Endothelial mitochondrial oxidative stress determines podocyte depletion in segmental glomerulosclerosis.
Daehn I; Casalena G; Zhang T; Shi S; Fenninger F; Barasch N; Yu L; D'Agati V; Schlondorff D; Kriz W; Haraldsson B; Bottinger EP
J Clin Invest; 2014 Apr; 124(4):1608-21. PubMed ID: 24590287
[TBL] [Abstract][Full Text] [Related]
4. Aberrant Notch1-dependent effects on glomerular parietal epithelial cells promotes collapsing focal segmental glomerulosclerosis with progressive podocyte loss.
Ueno T; Kobayashi N; Nakayama M; Takashima Y; Ohse T; Pastan I; Pippin JW; Shankland SJ; Uesugi N; Matsusaka T; Nagata M
Kidney Int; 2013 Jun; 83(6):1065-75. PubMed ID: 23447065
[TBL] [Abstract][Full Text] [Related]
5. Fn14 in podocytes and proteinuric kidney disease.
Sanchez-Niño MD; Poveda J; Sanz AB; Mezzano S; Carrasco S; Fernandez-Fernandez B; Burkly LC; Nair V; Kretzler M; Hodgin JB; Ruiz-Ortega M; Selgas R; Egido J; Ortiz A
Biochim Biophys Acta; 2013 Dec; 1832(12):2232-43. PubMed ID: 23999007
[TBL] [Abstract][Full Text] [Related]
6. TGF-beta1 reduces Wilms' tumor suppressor gene expression in podocytes.
Sakairi T; Abe Y; Kopp JB
Nephrol Dial Transplant; 2011 Sep; 26(9):2746-52. PubMed ID: 21378152
[TBL] [Abstract][Full Text] [Related]
7. Transient receptor potential channel 6 (TRPC6) protects podocytes during complement-mediated glomerular disease.
Kistler AD; Singh G; Altintas MM; Yu H; Fernandez IC; Gu C; Wilson C; Srivastava SK; Dietrich A; Walz K; Kerjaschki D; Ruiz P; Dryer S; Sever S; Dinda AK; Faul C; Reiser J
J Biol Chem; 2013 Dec; 288(51):36598-609. PubMed ID: 24194522
[TBL] [Abstract][Full Text] [Related]
8. CD147/Basigin Deficiency Prevents the Development of Podocyte Injury through FAK Signaling.
Yoshioka T; Kosugi T; Masuda T; Watanabe T; Ryuge A; Nagaya H; Maeda K; Sato Y; Katsuno T; Kato N; Ishimoto T; Yuzawa Y; Maruyama S; Kadomatsu K
Am J Pathol; 2019 Jul; 189(7):1338-1350. PubMed ID: 31014956
[TBL] [Abstract][Full Text] [Related]
9. Soluble RARRES1 induces podocyte apoptosis to promote glomerular disease progression.
Chen A; Feng Y; Lai H; Ju W; Li Z; Li Y; Wang A; Hong Q; Zhong F; Wei C; Fu J; Guan T; Liu B; Kretzler M; Lee K; He JC
J Clin Invest; 2020 Oct; 130(10):5523-5535. PubMed ID: 32634130
[TBL] [Abstract][Full Text] [Related]
10. Gα12 activation in podocytes leads to cumulative changes in glomerular collagen expression, proteinuria and glomerulosclerosis.
Boucher I; Yu W; Beaudry S; Negoro H; Tran M; Pollak MR; Henderson JM; Denker BM
Lab Invest; 2012 May; 92(5):662-75. PubMed ID: 22249312
[TBL] [Abstract][Full Text] [Related]
11. Podocyte-Specific Induction of Krüppel-Like Factor 15 Restores Differentiation Markers and Attenuates Kidney Injury in Proteinuric Kidney Disease.
Guo Y; Pace J; Li Z; Ma'ayan A; Wang Z; Revelo MP; Chen E; Gu X; Attalah A; Yang Y; Estrada C; Yang VW; He JC; Mallipattu SK
J Am Soc Nephrol; 2018 Oct; 29(10):2529-2545. PubMed ID: 30143559
[TBL] [Abstract][Full Text] [Related]
12. Receptor activator of NF-kappaB and podocytes: towards a function of a novel receptor-ligand pair in the survival response of podocyte injury.
Liu S; Shi W; Xiao H; Liang X; Deng C; Ye Z; Mei P; Wang S; Liu X; Shan Z; Liang Y; Zhang B; Wang W; Liu Y; Xu L; Xia Y; Ma J; Li Z
PLoS One; 2012; 7(7):e41331. PubMed ID: 22848465
[TBL] [Abstract][Full Text] [Related]
13. SRGAP1 Controls Small Rho GTPases To Regulate Podocyte Foot Process Maintenance.
Rogg M; Maier JI; Dotzauer R; Artelt N; Kretz O; Helmstädter M; Abed A; Sammarco A; Sigle A; Sellung D; Dinse P; Reiche K; Yasuda-Yamahara M; Biniossek ML; Walz G; Werner M; Endlich N; Schilling O; Huber TB; Schell C
J Am Soc Nephrol; 2021 Mar; 32(3):563-579. PubMed ID: 33514561
[TBL] [Abstract][Full Text] [Related]
14. Rap1GAP inhibits tumor growth in oropharyngeal squamous cell carcinoma.
Zhang Z; Mitra RS; Henson BS; Datta NS; McCauley LK; Kumar P; Lee JS; Carey TE; D'Silva NJ
Am J Pathol; 2006 Feb; 168(2):585-96. PubMed ID: 16436672
[TBL] [Abstract][Full Text] [Related]
15. Role of the small GTPase Rap1 for integrin activity regulation in endothelial cells and angiogenesis.
Carmona G; Göttig S; Orlandi A; Scheele J; Bäuerle T; Jugold M; Kiessling F; Henschler R; Zeiher AM; Dimmeler S; Chavakis E
Blood; 2009 Jan; 113(2):488-97. PubMed ID: 18805968
[TBL] [Abstract][Full Text] [Related]
16. Podocyte injury-driven lipid peroxidation accelerates the infiltration of glomerular foam cells in focal segmental glomerulosclerosis.
Hara S; Kobayashi N; Sakamoto K; Ueno T; Manabe S; Takashima Y; Hamada J; Pastan I; Fukamizu A; Matsusaka T; Nagata M
Am J Pathol; 2015 Aug; 185(8):2118-31. PubMed ID: 26072030
[TBL] [Abstract][Full Text] [Related]
17. Focal and segmental glomerulosclerosis in murine models: a histological and ultrastructural characterization with immunohistochemistry correlation of glomerular CD44 and WT1 expression.
Husain S; Ginawi I; Bashir AI; Kfoury H; Al Johani TE; Hagar H; Raddaoui L; Al Ghonaim M; Alsuwaida A
Ultrastruct Pathol; 2018; 42(5):430-439. PubMed ID: 30285525
[TBL] [Abstract][Full Text] [Related]
18. Connective tissue growth factor modulates podocyte actin cytoskeleton and extracellular matrix synthesis and is induced in podocytes upon injury.
Fuchshofer R; Ullmann S; Zeilbeck LF; Baumann M; Junglas B; Tamm ER
Histochem Cell Biol; 2011 Sep; 136(3):301-19. PubMed ID: 21814837
[TBL] [Abstract][Full Text] [Related]
19. Reduced podocyte expression of alpha3beta1 integrins and podocyte depletion in patients with primary focal segmental glomerulosclerosis and chronic PAN-treated rats.
Chen CA; Hwang JC; Guh JY; Chang JM; Lai YH; Chen HC
J Lab Clin Med; 2006 Feb; 147(2):74-82. PubMed ID: 16459165
[TBL] [Abstract][Full Text] [Related]
20. The Hippo pathway regulator KIBRA promotes podocyte injury by inhibiting YAP signaling and disrupting actin cytoskeletal dynamics.
Meliambro K; Wong JS; Ray J; Calizo RC; Towne S; Cole B; El Salem F; Gordon RE; Kaufman L; He JC; Azeloglu EU; Campbell KN
J Biol Chem; 2017 Dec; 292(51):21137-21148. PubMed ID: 28982981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
